Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cells, covering 2020-08-20 to 2020-08-20. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB [Phase 1, Phase 2]